Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Viruses|November 27, 2021
COVEVOL: Natural Evolution at 6 Months of COVID-19Louise Messin, Marc Puyraveau, Yousri Benabdallah, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 21, 2024
Linezolid in enterococcal urinary tract infection: a multicentre studyLéa Malinowski, Souheil Zayet, Myriam Chiaruzzi, et al.
Viruses|November 25, 2023
Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent PlasmaLéa Da Silva, Timothée Klopfenstein, Vincent Gendrin, et al.
Open Forum Infectious Diseases|November 19, 2020
Tularemia: A Case Series of Patients Diagnosed at the National Reference Center for Rickettsioses From 2008 to 2017Anne Darmon-Curti, François Darmon, Sophie Edouard, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|August 18, 2020
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patientsTimothée Klopfenstein, Souheil Zayet, Anne Lohse, et al.
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
Journal of Medical Virology|June 7, 2022
Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID studyJulien Mercier, Molka Osman, Kevin Bouiller, et al.
Life (Basel, Switzerland)|July 27, 2022
Asthma and Cacosmia Could Be Predictive Factors of Olfactory Dysfunction Persistence 9 Months after SARS-CoV-2 Infection: The ANOSVID StudyCan Tipirdamaz, Souheil Zayet, Molka Osman, et al.
Infectious Diseases and Therapy|July 11, 2021
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 PneumoniaTimothée Klopfenstein, Vincent Gendrin, Aurélie Gerazime, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 26, 2024
CRP under 130 mg/L rules out the diagnosis of Legionella pneumophila serogroup 1 (URINELLA Study)Timothée Klopfenstein, Souheil Zayet, Samantha Poloni, et al.
Pageof 6